MORRISVILLE, NC, February 6, 2017 – Worldwide Clinical Trials (www.worldwide.com) has been ranked as the industry’s #1 provider of Overall Contract Research, which includes non-clinical research services, in the “2017 Nice Insight Preclinical and Clinical Contract Research Survey.” The survey examines market perceptions of Clinical Research Organizations (CROs) using data collected from key industry executives.
The study, undertaken by Nice Insight, analyzed the responses of 608 outsourcing-facing pharmaceutical and biotechnology executives from around the world on leading CROs. Gauging their perceptions across a range of technical, operational, and service capabilities, the participants consistently perceived Worldwide Clinical Trials as the top provider of clinical research related services.
Commenting on the survey findings, Peter Benton, President and COO at Worldwide, said: “For many years, Worldwide Clinical Trials and our depth of clinical expertise and breadth of global capabilities has been one of the industry’s best kept secrets. With this 2017 survey ranking, it looks like that secret is getting out and customers who are demanding a better experience and looking for more – proactive insight, dogged determination, rigorous processes and a commitment to getting it right – are taking notice, choosing Worldwide and recognizing what we can do. I’m very proud of this recognition, on behalf of the entire Worldwide Clinical Trials team.”
Nice Insight, the research division of That’s Nice, A Science Agency, has conducted this annual survey of the CRO industry for the past six years. The 2017 study identified 73 of the industry’s most prominent CROs, using responses from key decision-makers involved in clinical trials operations and management, R&D and analytical departments, as well as quality assurance and quality control. For more information about the survey, visit http://www.niceinsightcro.com/.